Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

Grifols SA (GRFS)

NASDAQ:GRFS

GRFS

Grifols SA

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Grifols SA (GRFS) Stock News & Sentiment

360 Followers

Grifols says on track to close Haier strategic alliance in first half of 2024

PremiumThe Fly

Grifols says on track to close Haier strategic alliance in first half of 2024

2d ago

Grifols SA’s Related Party Transactions: Navigating Conflicts of Interest and Investor Concerns

PremiumCompany Announcements

Grifols SA’s Related Party Transactions: Navigating Conflicts of Interest and Investor Concerns

18d ago

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

PremiumPress Releases

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

20d ago

Grifols announces commencement of refinancing process

PremiumThe Fly

Grifols announces commencement of refinancing process

28d ago

Grifols price target lowered to EUR 13 from EUR 18 at Barclays

PremiumThe Fly

Grifols price target lowered to EUR 13 from EUR 18 at Barclays

1M ago

Grifols says all liabilitites disclosed in audited financial statements

PremiumThe Fly

Grifols says all liabilitites disclosed in audited financial statements

1M ago

Grifols simplifies financial presentation, limits non-recurring items

PremiumThe Fly

Grifols simplifies financial presentation, limits non-recurring items

1M ago

More GRFS News >

GRFS News on the Web

2024-04-21

Grifols SA’s Related Party Transactions: Navigating Conflicts of Interest and Investor Concerns

TipRanks News

Bearish

2024-04-19

Grifols 2023 Annual Report on Form 20-F filed with the SEC

Yahoo Finance

Neutral

2024-04-18

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

Yahoo Finance

Neutral

2024-04-14

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

Yahoo Finance

Neutral

2024-04-10

Grifols Plans First Bond Sale Since Short Seller Attack

Yahoo Finance

Neutral

2024-04-09

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Zacks

Neutral

2024-04-04

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Yahoo Finance

Neutral

2024-04-01

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Zacks

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GRFS’s Media Buzz Sentiment?

Currently, no data Available

What is GRFS’s weekly average amount of articles?

Currently, no data Available

What is GRFS’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

RMDResmed

AMEDAmedisys

MORFMorphic Holding

NBIXNeurocrine

TAKTakeda Pharmaceutical Company

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing